Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Idaho

36 recruiting clinical trials across 10 cities in Idaho (ID). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
36
Total Trials
36
Recruiting Now
10
Cities
20
Conditions

Recruiting Trials in Idaho

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04739072

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come...

Sponsor: M.d. Anderson Cancer CenterEnrolling: 100010 locations
Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8+11
RECRUITINGNCT04889872

PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR

This study objective is to establish the safety and effectiveness of the Edwards SAPIEN 3 / SAPIEN 3 Ultra / SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve systems in subjects...

Sponsor: Edwards LifesciencesEnrolling: 225020 locations
Aortic Stenosis, CalcificAortic Valve Stenosis
RECRUITINGPhase 3NCT05156398

Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years...

Sponsor: PfizerEnrolling: 64020 locations
Migraine
RECRUITINGPhase 3NCT05219617

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and...

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic)...

Sponsor: SK Life Science, Inc.Enrolling: 25220 locations
SeizuresLennox Gastaut Syndrome
RECRUITINGPhase 4NCT05303636

LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD) at the lumbar spine after 12...

Sponsor: Insud PharmaEnrolling: 171020 locations
Change in Bone Mineral DensityBone Loss
RECRUITINGPhase 2 / Phase 3NCT05330182

LMN-201 for Prevention of C. Difficile Infection Recurrence

This is a multisite study to evaluate the safety, tolerability, and efficacy of LMN-201 in participants recently diagnosed with CDI who are scheduled to receive or are receiving...

Sponsor: Lumen Bioscience, Inc.Enrolling: 37516 locations
Clostridioides Difficile Infection
RECRUITINGPhase 4NCT05548283

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a...

Sponsor: Chris GossEnrolling: 73020 locations
Cystic FibrosisCystic Fibrosis Pulmonary Exacerbation
RECRUITINGPhase 1 / Phase 2NCT05655182

A Study of BLB-201 RSV Vaccine in Infants and Children

This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of...

Sponsor: Blue Lake Biotechnology Inc.Enrolling: 13711 locations
Respiratory Syncytial Virus Infections
RECRUITINGPhase 3NCT05667142

A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of XEN1101 administered as...

Sponsor: Xenon Pharmaceuticals Inc.Enrolling: 16020 locations
Primary Generalized Tonic-Clonic Seizures
RECRUITINGPhase 3NCT05716100

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101...

Sponsor: Xenon Pharmaceuticals INC.Enrolling: 36020 locations
Focal Onset Seizures
RECRUITINGPhase 3NCT06094010

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission...

This study consists of two parts: Part A Surveillance and Part B Transmission. The main purpose of Part A is to evaluate the prevalence of pre-dose and treatment-emergent amino...

Sponsor: Hoffmann-La RocheEnrolling: 75020 locations
Influenza
RECRUITINGPhase 2NCT06369298

Study of JK07 in Patients With Chronic Heart Failure

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart...

Sponsor: Salubris Biotherapeutics IncEnrolling: 28220 locations
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction
RECRUITINGNCT06390345

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

The investigators will conduct a Type I hybrid effectiveness-implementation study to test an integrated telehealth intervention among 400 overweight and obese patients with...

Sponsor: Seattle Institute for Biomedical and Clinical ResearchEnrolling: 4005 locations
Chronic Obstructive Pulmonary DiseaseObstructive Sleep ApneaOverweight and Obesity
RECRUITINGPhase 3NCT06470243

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to...

This phase III trial compares the effect of adding carboplatin to the standard of care chemotherapy drug cabazitaxel versus cabazitaxel alone in treating prostate cancer that...

Sponsor: SWOG Cancer Research NetworkEnrolling: 52820 locations
Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
RECRUITINGPhase 3NCT06475989

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

This phase III trial compares the effect of cabozantinib versus combination dabrafenib and trametinib for the treatment of patients with differentiated thyroid cancer that does...

Sponsor: ECOG-ACRIN Cancer Research GroupEnrolling: 26420 locations
Refractory Differentiated Thyroid Gland Carcinoma
RECRUITINGNCT06504589

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research...

Sponsor: Nicole HamblettEnrolling: 40020 locations
Cystic Fibrosis
RECRUITINGPhase 3NCT06545955

A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in...

The pivotal phase 3 trial (rAd-IFN-CS 003) evaluating the efficacy of nadofaragene firadenovec showed that 55 (53.4%) of 103 subjects with CIS ± high-grade Ta/T1 achieved a...

Sponsor: Ferring PharmaceuticalsEnrolling: 25020 locations
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
RECRUITINGPhase 4NCT06572228

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to...

This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the airways narrow and swell, making...

Sponsor: Regeneron PharmaceuticalsEnrolling: 25020 locations
Asthma
RECRUITINGNCT06578195

ASSESS ALL ALS Study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis...

Sponsor: St. Joseph's Hospital and Medical Center, PhoenixEnrolling: 200020 locations
Amyotrophic Lateral Sclerosis
RECRUITINGNCT06581861

PREVENT ALL ALS Study

The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis...

Sponsor: St. Joseph's Hospital and Medical Center, PhoenixEnrolling: 60020 locations
Amyotrophic Lateral Sclerosis
RECRUITINGPhase 3NCT06623422

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung...

The goal of this study is to learn if people who receive intismeran autogene and pembrolizumab after surgery are cancer-free longer than people who receive placebo and...

Sponsor: Merck Sharp & Dohme LLCEnrolling: 68020 locations
Carcinoma, Non-Small-Cell Lung
RECRUITINGPhase 3NCT06641466

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual...

The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstrual period (PMP) for intermittent prevention of migraine in...

Sponsor: PfizerEnrolling: 72320 locations
Menstrual Migraine
RECRUITINGPhase 3NCT06719141

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of...

Sponsor: Longboard PharmaceuticalsEnrolling: 32020 locations
Developmental and Epileptic Encephalopathy
RECRUITINGNCT06735534

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE...

The ReMATCH Study is a prospective, single arm, open label, multi-center, study utilizing the FARAPULSE PFA System, including the FARAWAVE and FARAPOINT PFA Catheters.

Sponsor: Boston Scientific CorporationEnrolling: 37620 locations
Persistent Atrial Fibrillation
RECRUITINGPhase 3NCT06937086

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active...

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo,...

Sponsor: Eli Lilly and CompanyEnrolling: 35020 locations
Ulcerative ColitisObesity or Overweight
RECRUITINGPhase 3NCT06972459

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related...

The main purpose of this study is to see how orforglipron, compared with placebo, helps reduce body weight in participants with obesity or with overweight and at least one other...

Sponsor: Eli Lilly and CompanyEnrolling: 60020 locations
ObesityOverweight
RECRUITINGPhase 3NCT06993792

A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2...

The purpose of this Master Protocol is to support two studies to see how well and how safely orforglipron works compared to placebo in participants who have obesity or overweight...

Sponsor: Eli Lilly and CompanyEnrolling: 120020 locations
ObesityOverweightType 2 Diabetes
RECRUITINGPhase 2NCT06999603

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

The goal of this Phase 2 study is to assess about the safety, antiviral biomarker responses and efficacy of SNG001 when given to patients requiring invasive mechanical ventilation...

Sponsor: Synairgen Research Ltd.Enrolling: 55020 locations
Viral Pneumonia
RECRUITINGPhase 3NCT07000084

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle...

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive...

Sponsor: Alliance for Clinical Trials in OncologyEnrolling: 33020 locations
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8
RECRUITINGPhase 3NCT07013474

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination...

Sponsor: PfizerEnrolling: 30020 locations
COVID-19 Infection

Showing 30 of 36 trials in Idaho. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 36 clinical trials actively recruiting participants in Idaho. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Idaho include Clostridioides Difficile Infection, Cystic Fibrosis, Influenza, Amyotrophic Lateral Sclerosis, Obesity. Each has multiple active trials across research centers in the state.

Major trial sites in Idaho include Boise, Meridian, Idaho Falls, Coeur d'Alene, Post Falls. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.